Thanks. Pretty confusing. Are we to read into it re 'for use in the 2b trial' meaning for use in the 2b trial, but another $7.4m of costs will be req to take us to futility?
if so thats extremely misleading.
- Forums
- ASX - By Stock
- PER
- Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial
Ann: Manufacture of ATL1102 clinical supplies for Phase IIb trial, page-42
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.81M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.3¢ | $4.636K | 63.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 103205 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 178307 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3205 | 0.073 |
2 | 127777 | 0.072 |
1 | 20000 | 0.071 |
2 | 9545 | 0.070 |
1 | 137681 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 178307 | 2 |
0.076 | 143169 | 1 |
0.077 | 80000 | 1 |
0.078 | 50000 | 1 |
0.080 | 131000 | 2 |
Last trade - 10.23am 02/05/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
Previous Video
Next Video
SPONSORED BY The Market Online